BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 19419797)

  • 1. [Fever and thin-walled cavitary lung lesions].
    Ramos A; Daza R; Alvarez-Espejo T; Guzmán MF
    Enferm Infecc Microbiol Clin; 2009 Jun; 27(6):363-4. PubMed ID: 19419797
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment with a macrolide-containing regimen for Mycobacterium kansasii pulmonary disease.
    Moon SM; Choe J; Jhun BW; Jeon K; Kwon OJ; Huh HJ; Lee NY; Daley CL; Koh WJ
    Respir Med; 2019 Mar; 148():37-42. PubMed ID: 30827472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pulmonary Mycobacterium fortuitum infection with multiple nodular shadows in a healthy man].
    Inoue T; Tanaka E; Sakuramoto M; Maeda Y; Maniwa K; Taguchi Y
    Kekkaku; 2004 Oct; 79(10):573-7. PubMed ID: 15631109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Swelling of right knee in an immunologically compromised patient].
    Cajigas-Pezo D; Lorenzo-Hernandez A; Vives-Rivero GR; Rentero-Martínez Z
    Enferm Infecc Microbiol Clin; 2012 Oct; 30(8):481-2. PubMed ID: 22521279
    [No Abstract]   [Full Text] [Related]  

  • 5. Ultrashort-course chemotherapy for culture-negative pulmonary tuberculosis--a qualified success.
    Cowie RL; Langton ME; Escreet BC
    S Afr Med J; 1985 Dec; 68(12):879-80. PubMed ID: 4071345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid oral tolerance induction to isoniazid and pyrazinamide and controlled administration of ethambutol: clinical case.
    Rodrigues Carvalho S; Silva I; Leiria-Pinto P; Rosado-Pinto J
    Allergol Immunopathol (Madr); 2009; 37(6):336-8. PubMed ID: 19875222
    [No Abstract]   [Full Text] [Related]  

  • 7. Temporal interferon-gamma release response to Mycobacterium kansasii infection in an anorexia nervosa patient.
    Cosson MA; Bertrand JB; Martin C; Veziris N; Picard C; Goulvestre C; Coignard S; Benoit JP; Silvera S; Moro MR; Poyart C; Morand PC
    J Med Microbiol; 2012 Nov; 61(Pt 11):1617-1620. PubMed ID: 22859583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Assessment of the use of a multicomponent drug in the treatment of new cases of pulmonary tuberculosis].
    Semenova OV
    Probl Tuberk Bolezn Legk; 2003; (11):22-5. PubMed ID: 14689793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An unusual lung mass post stem cell transplantation.
    Lyons J; Vandenberghe E; Fahy R; McDonnell C; Keane J; McLaughlin AM
    Transpl Infect Dis; 2014 Aug; 16(4):672-5. PubMed ID: 24995624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two excellent management tools for national tuberculosis programmes: history of prior treatment and sputum status at two months.
    Trébucq A; Rieder HL
    Int J Tuberc Lung Dis; 1998 Mar; 2(3):184-6. PubMed ID: 9526189
    [No Abstract]   [Full Text] [Related]  

  • 11. Management of disease due to Mycobacterium kansasii.
    Griffith DE
    Clin Chest Med; 2002 Sep; 23(3):613-21, vi. PubMed ID: 12370997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Disseminated disease by Mycobacterium kansasii resistant to isoniazid and rifampin in patients] with AIDS].
    Ibarrola M; Baraia-Etxaburu J; Sánchez R; Teira R; Unzaga J; Miguel Santamaría J
    Enferm Infecc Microbiol Clin; 2001 Feb; 19(2):80-2. PubMed ID: 11333577
    [No Abstract]   [Full Text] [Related]  

  • 13. Coccidioides immitis and Mycobacterium tuberculosis diagnosed by endoscopic ultrasound.
    Naidu VG; Tammineni AK; Biscopink RJ; Davis TL; Veerabagu MP
    J S C Med Assoc; 2009 Feb; 105(1):4-7. PubMed ID: 19331085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-tuberculosis 4FDC tablets--mystery to chemistry.
    Dekker TG; Lötter AP
    Int J Tuberc Lung Dis; 2003 Mar; 7(3):205-6. PubMed ID: 12661831
    [No Abstract]   [Full Text] [Related]  

  • 15. [Efficiency of an intensive stage of chemotherapy for tuberculosis in elderly and senile patients].
    Karachunskiĭ MA; Uvarova TE
    Probl Tuberk Bolezn Legk; 2004; (3):19-21. PubMed ID: 15338894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rifampin in association with isoniazid, streptomycin, and ethambutol, respectively, in the initial treatment of pulmonary tuberculosis.
    Nitti V; Catena E; Delli Veneri F; De Michele G; Marra A
    Am Rev Respir Dis; 1971 Mar; 103(3):329-37. PubMed ID: 5005040
    [No Abstract]   [Full Text] [Related]  

  • 17. A ten-year clinical experience with Mycobacterium kansasii.
    Rauscher CR; Kerby G; Ruth WE
    Chest; 1974 Jul; 66(1):17-9. PubMed ID: 4846114
    [No Abstract]   [Full Text] [Related]  

  • 18. Cavitary lung infection caused by Mycobacterium flavescens.
    Casimir MT; Fainstein V; Papadopolous N
    South Med J; 1982 Feb; 75(2):253-4. PubMed ID: 7058379
    [No Abstract]   [Full Text] [Related]  

  • 19. Pulmonary Infection Caused by Mycobacterium shinjukuense.
    Oshima K; Yokouchi H; Minemura H; Saito J; Tanino Y; Munakata M
    Ann Am Thorac Soc; 2015 Jun; 12(6):958-9. PubMed ID: 26075560
    [No Abstract]   [Full Text] [Related]  

  • 20. [Recommendations for the therapy of tuberculosis. (Position: December, 1988)].
    Merkel S; Fischer P; Weinecke W
    Z Erkr Atmungsorgane; 1989; 173(1):87-96. PubMed ID: 2800620
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 21.